Bremazocine is a potent opioid kappa receptor agonist with analgesic activity. Bremazocine induces peripheral analgesia by releasing endogenous norepinephrine. The analgesic effect of bremazocine is associated with interaction with adenosine receptors. Bremazocine produces a dose-dependent peripheral analgesia after topical application. The effect of bremazocine is affected by nonselective alpha(2) adrenaline receptor antagonists, suggesting that it acts through a norepinephrine pathway[1].
Molecular Weight:
315.45
CAS Number:
[75684-07-0]
Formula:
C20H29NO2
Target:
Adrenergic Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
